NLS Pharmaceutics AG (NASDAQ: NLSP) Announces FDA Acceptance Of Its Clinical Trials To Treat Narcolepsy

NLS Pharmaceutics AG (NASDAQ: NLSP) in its latest announcement, made it official that the U.S. Food and Drug Administration (FDA) has accepted the company’s recently filed application. The new drug application is about (IND) for Quilience® (mazindol extended-release, or mazindol ER). According to sources, the same is the company’s lead […]